Gulfstream Daily Brief

Regulatory intelligence and policy · Issue 021

MHRA updates MRI safety guidance, export restrictions, and September safety communications

Today’s UK regulatory updates span clinical MRI safety, medicine supply controls, device notices, and the MHRA’s regulatory science programme.

By Scott Morvay, Founder September 30, 2026 Official sources linked

MHRA

MHRA publishes MRI equipment safety guidelines

The guidance provides safety information for users of magnetic resonance imaging equipment in clinical use.

Read the official source

MHRA

MHRA updates guidance on medicines that cannot be exported or hoarded

The guidance sets out medicines that cannot be exported from the UK or hoarded because they are needed for UK patients.

Read the official source

MHRA

MHRA lists recent Field Safety Notices

The communication lists Field Safety Notices issued from September 21 to 25, 2026.

Read the official source

MHRA

September safety roundup consolidates medicines and device advice

MHRA summarized its latest safety advice for users of medicines and medical devices.

Read the official source

MHRA

MHRA outlines its regulatory science centres programme

The Centres of Excellence for Regulatory Science and Innovation programme is intended to advance healthcare and help patients benefit from innovation and new treatments sooner.

Read the official source

Why this matters

Regulatory affairs teams should account for current MHRA safety information across clinical equipment, devices, and medicines. The export guidance also remains relevant to UK supply controls, while the CERSI programme signals continued attention to regulatory science and healthcare innovation.

Scott Morvay

Founder, Gulfstream Intelligence

This brief provides general regulatory news and educational information. It is not legal or regulatory advice.